SCHEMBL29601266

SCHEMBL29601266

CON(C)C(=O)c1ncccc1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 7/20 0.49
HCRTR2 O43614 7/20 0.49
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TRPM8 Q7Z2W7 1/20 0.41
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 3/20 0.40
ATM Q13315 1/20 0.40
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TACR1 P25103 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20754976 0.83 HTR7 (0.42) SMN1; SMN2MEN1KMT2ATRPM8ALDH1A1
SCHEMBL70767 0.78 L3MBTL1 (0.41) HCRTR1HCRTR2SMN1; SMN2TRPM8KDM4E
SCHEMBL698991 0.78 L3MBTL1 (0.55) HCRTR1HCRTR2SMN1; SMN2MEN1KMT2A
SCHEMBL3488783 0.78 TRPM8 (0.45) TRPM8KDM4EALDH1A1HPGDHSD17B10
SCHEMBL569266 0.77 TRPM8 (0.40) KMT2ATRPM8KDM4EALDH1A1
SCHEMBL7072815 0.77 KDM4E (0.40) SMN1; SMN2MEN1KMT2AKDM4EALDH1A1
SCHEMBL3488694 0.77 NFE2L2 (0.46) HCRTR1HCRTR2SMN1; SMN2MEN1KMT2A
SCHEMBL2893762 0.77 L3MBTL1 (0.40) HCRTR1HCRTR2SMN1; SMN2MEN1KMT2A
SCHEMBL8986031 0.76 MEN1 (0.69) SMN1; SMN2MEN1KMT2ATRPM8KDM4E
SCHEMBL6902624 0.76 KDM4E (0.46) HCRTR1HCRTR2SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed